Altimmune, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | $0 | $0 | $0 | $0 | $0 | $0 | |
| −$23 | −$23 | −$19 | −$22 | −$20 | −$23 | −$25 | −$24 | |
| −$0.12 | −$0.18 | −$0.21 | −$0.27 | −$0.26 | −$0.32 | −$0.35 | −$0.34 | |
| 185 | 124 | 89 | 81 | 76 | 71 | 71 | 71 |
Trend